\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ frontal\\ lobe\\ biopsy\\:\\ \\ \\ spongioform\\ encephalopathy\\ consistent\\ with\\ creutzfeldt\\-jacob\\ disease\\.\ \(0\)\
\-\ brain\\ mri\\ scans\\ approximately\\ 6\\ months\\ apart\\ show\\ progressive\\ diffuse\\ cortical\\ atrophy\\,\\ t2\\/flair\\ and\\ diffusion\\ increased\\ signal\\ within\\ the\\ basal\\ ganglia\\.\\ \\ mild\\ increased\\ diffusion\\ signal\\ is\\ seen\\ in\\ the\\ posterior\\ thalamus\\ \\(pulvinar\\)\ \(0\)\
\-\ correspoding\\ relatively\\ decreased\\ adc\\ map\\ basal\\ ganglia\\ signal\\.\ \(0\)\
\-\ mr\\ spectroscopy\\ demonstrated\\ a\\ decrease\\ in\\ naa\\ peak\\.\ \(0\)\
\-\ spongioform\\ encephalopathy\\,\\ presumed\\ variant\\ creutzfeldt\\-jacob\\ disease\ \(0\)\
\-\ cruetzfeldt\\-jacob\\ disease\ \(0\)\
\-\ variant\\ creutzfeldt\\-jacob\\ disease\ \(0\)\
\-\ other\\ transmissible\\ spongioform\\ encephalopathies\ \(0\)\
\-\ diffuse\\ ischemic\\ insult\ \(0\)\
\-\ less\\ likely\\:\ \(2\)\
\-\ methanol\\ \\-\\ putamen\ \(0\)\
\-\ carbon\\ monoxide\\ \\-\\ globus\\ pallidus\\ \ \(0\)\
\-\ deposition\\ of\\ iron\\ or\\ copper\ \(0\)\
\-\ neoplastic\\ infiltration\\â\\€\\”particularly\\ of\\ lymphoma\\ or\\ glioma\\.\ \(0\)\
\-\ 25\\ y\\/o\\ with\\ new\\ onset\\ progrssive\\ dementia\\,\\ myclonus\\,\\ eeg\\ abnormalities\\,\\ history\\ of\\ eating\\ raw\\ sheep\\'s\\ brain\\ approximately\\ 2\\ years\\ ago\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ spongioform\\:\\ 0\\.1740655519240238\ \(0\)\
\-\ creutzfeldt\\-jacob\\:\\ 0\\.1740655519240238\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.07565907954959754\ \(0\)\
\-\ correspoding\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ cruetzfeldt\\-jacob\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ infiltration\\â\\€\\”particularly\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ progrssive\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ myclonus\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ sheep\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ ganglia\\:\\ 0\\.06575740101467942\ \(0\)\
\-\ variant\\:\\ 0\\.061211823994033805\ \(0\)\
\-\ pulvinar\\:\\ 0\\.061070460476740994\ \(0\)\
\-\ basal\\:\\ 0\\.0585795112502011\ \(0\)\
\-\ transmissible\\:\\ 0\\.058021850641341265\ \(0\)\
\-\ encephalopathies\\:\\ 0\\.058021850641341265\ \(0\)\
\-\ raw\\:\\ 0\\.058021850641341265\ \(0\)\
\-\ diffusion\\:\\ 0\\.057520087777259574\ \(0\)\
\-\ copper\\:\\ 0\\.05585882754020005\ \(0\)\
\-\ naa\\:\\ 0\\.05281021770480032\ \(0\)\
\-\ t2\\/flair\\:\\ 0\\.0516511900369262\ \(0\)\
\-\ methanol\\:\\ 0\\.0516511900369262\ \(0\)\
\-\ signal\\:\\ 0\\.0508212254948747\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.04896942354114626\ \(0\)\
\-\ pallidus\\:\\ 0\\.04896942354114626\ \(0\)\
\-\ apart\\:\\ 0\\.04699675989853354\ \(0\)\
\-\ insult\\:\\ 0\\.04699675989853354\ \(0\)\
\-\ putamen\\:\\ 0\\.046439557100385255\ \(0\)\
\-\ monoxide\\:\\ 0\\.046439557100385255\ \(0\)\
\-\ globus\\:\\ 0\\.045435561667118166\ \(0\)\
\-\ carbon\\:\\ 0\\.04454997493285965\ \(0\)\
\-\ eeg\\:\\ 0\\.04414345447218088\ \(0\)\
\-\ dementia\\:\\ 0\\.04304117271133971\ \(0\)\
\-\ thalamus\\:\\ 0\\.04270694893261164\ \(0\)\
\-\ disease\\:\\ 0\\.042007144096712905\ \(0\)\
\-\ map\\:\\ 0\\.041501365097459914\ \(0\)\
\-\ iron\\:\\ 0\\.04046264074798009\ \(0\)\
\-\ approximately\\:\\ 0\\.03975665904594861\ \(0\)\
\-\ eating\\:\\ 0\\.03913233467159604\ \(0\)\
\-\ diffuse\\:\\ 0\\.03890236722368894\ \(0\)\
\-\ brain\\:\\ 0\\.03866694020004153\ \(0\)\
\-\ adc\\:\\ 0\\.038360498926783386\ \(0\)\
\-\ peak\\:\\ 0\\.03657349402545165\ \(0\)\
\-\ presumed\\:\\ 0\\.03643027451439381\ \(0\)\
\-\ deposition\\:\\ 0\\.03588321170024021\ \(0\)\
\-\ atrophy\\:\\ 0\\.03314886599024244\ \(0\)\
\-\ neoplastic\\:\\ 0\\.03287870050733971\ \(0\)\
\-\ increased\\:\\ 0\\.03143586138044595\ \(0\)\
\-\ ischemic\\:\\ 0\\.03128991032939079\ \(0\)\
\-\ scans\\:\\ 0\\.02991907155650391\ \(0\)\
\-\ decrease\\:\\ 0\\.029400328161865177\ \(0\)\
\-\ glioma\\:\\ 0\\.02896747213313226\ \(0\)\
\-\ \\-\\:\\ 0\\.027544788852757345\ \(0\)\
\-\ relatively\\:\\ 0\\.027492203945503526\ \(0\)\
\-\ 25\\:\\ 0\\.02597162600193288\ \(0\)\
\-\ progressive\\:\\ 0\\.02539427906047596\ \(0\)\
\-\ ago\\:\\ 0\\.023915254291708633\ \(0\)\
\-\ abnormalities\\:\\ 0\\.02359973399773095\ \(0\)\
\-\ cortical\\:\\ 0\\.023421615417863247\ \(0\)\
\-\ biopsy\\:\\ 0\\.022794686027344063\ \(0\)\
\-\ new\\:\\ 0\\.022389383284214723\ \(0\)\
\-\ less\\:\\ 0\\.021758947400922424\ \(0\)\
\-\ mr\\:\\ 0\\.0204150336236574\ \(0\)\
\-\ onset\\:\\ 0\\.020281362600940975\ \(0\)\
\-\ frontal\\:\\ 0\\.020182646123935017\ \(0\)\
\-\ show\\:\\ 0\\.019722976951064855\ \(0\)\
\-\ 6\\:\\ 0\\.019188873393796047\ \(0\)\
\-\ decreased\\:\\ 0\\.01910343159943278\ \(0\)\
\-\ years\\:\\ 0\\.018866489752018663\ \(0\)\
\-\ demonstrated\\:\\ 0\\.018852781822984718\ \(0\)\
\-\ lymphoma\\:\\ 0\\.018362395747289366\ \(0\)\
\-\ likely\\:\\ 0\\.018122480946884633\ \(0\)\
\-\ y\\/o\\:\\ 0\\.01779420323172662\ \(0\)\
\-\ months\\:\\ 0\\.01754843078714336\ \(0\)\
\-\ lobe\\:\\ 0\\.01728816051070326\ \(0\)\
\-\ \\:\\:\\ 0\\.016996613774295715\ \(0\)\
\-\ mild\\:\\ 0\\.016919198901737872\ \(0\)\
\-\ consistent\\:\\ 0\\.01575412232203912\ \(0\)\
\-\ or\\:\\ 0\\.01506049246561966\ \(0\)\
\-\ posterior\\:\\ 0\\.014809312396259012\ \(0\)\
\-\ other\\:\\ 0\\.014809312396259012\ \(0\)\
\-\ mri\\:\\ 0\\.014761472593343006\ \(0\)\
\-\ \\'s\\:\\ 0\\.014165764047872518\ \(0\)\
\-\ 2\\:\\ 0\\.013835372154214633\ \(0\)\
\-\ seen\\:\\ 0\\.012696448233591656\ \(0\)\
\-\ within\\:\\ 0\\.012256627130722418\ \(0\)\
\-\ \\,\\:\\ 0\\.010177070132228848\ \(0\)\
\-\ history\\:\\ 0\\.008873793516594612\ \(0\)\
\-\ left\\:\\ 0\\.007188761423104622\ \(0\)\
\-\ in\\:\\ 0\\.006336800453236916\ \(0\)\
\-\ \\(\\:\\ 0\\.005431291174765868\ \(0\)\
\-\ \\)\\:\\ 0\\.005364945053483497\ \(0\)\
\-\ is\\:\\ 0\\.00422775021341899\ \(0\)\
\-\ a\\:\\ 0\\.0029819533971323403\ \(0\)\
\-\ of\\:\\ 0\\.0026279052811576335\ \(0\)\
\-\ the\\:\\ 0\\.0020789366120845983\ \(0\)\
\-\ with\\:\\ 0\\.0017594612945848079\ \(0\)\
\-\ \\.\\:\\ 0\\.0016014828314592305\ \(0\)\
\-\ and\\:\\ 0\\.0013534511709189356\ \(0\)\
